References
- Sanz MA, Lo Coco F. Modern approaches to treating acute promyelocytic leukemia. J Clin Oncol 2011;29:495–503.
- Micol JB, Raffoux E, Boissel N, . Do early events excluding patients with acute promyelocytic leukemia from trial enrollement modify treatment evaluation? Real-life management of 100 patients referred to the University Hospital Saint Louis between 200 and 2010. Blood 2010;116(Suppl. 1): Abstract 473.
- Park JH, Panageas KS, Schymura MJ, . A population-based study in APL suggests a higher early death rate and lower overall survival than commonly reported in clinical trials: data from Surveillance, Epidemiology, and End Results (SEER) program and the New York State Cancer Registry in the United States between 1992–2007. Blood 2011 June 8. [Epub ahead of print]
- Lo Coco F, Avvisati G, Vignetti M, . Front-line treament of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidations for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA group. Blood 2010;116:3171–3179.
- Mayer SA, Brun NC, Begtrup K, . Efficacy and safety of recombinant acrtivated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008;358:2127–2137.
- Brenner B, Hoffman R, Balashv D, . Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII. Clin Appl Thromb Hemost 2005;1:554–557.
- Franchini M, Veneri D, Lippi G. The potential role of recombinant activated factor VII in the management of critical hemato-oncological bleeding : a systematic review. Bone Marrow Transplant 2007;39:729–735.
- Zver S, Andoljsek D, Cernelc P. Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia. Eur J Haematol 2004;72:455–456.
- Zulfikar B, Kayiran SM. Successful treatment of massive gastrointestinal hemorrhage in acute biphenotypic leukemia with recombinant factor VIIa (NovoSeven). Blood Coag Fibrinolysis 2004;15: 261–263.
- Alimoghaddam K, Ghavamzadeh A, Jahani M. Use of Novoseven for arsenic trioxide-induced bleeding in APL. Am J Hematol 2006;81:720.